ESTABLISHING A SAFE AND EFFICACIOUS ANTI-GLIOBLASTOMA THERAPY

被引：0
|
作者：
del Genio, Carmen [1 ]
Nguyen, Sidney [1 ]
Shalit, Zachary [2 ]
Pizzi, Elizabeth [3 ]
Messay, Bamlak [4 ]
Fontaine, Dominique [1 ]
Shentu, Yujia [2 ]
Wishart, Heather [2 ]
Ford, James [2 ]
Micalizio, Glenn [2 ]
Gaur, Arti [1 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Dartmouth Coll, 1 Med Ctr Dr, Lebanon, NH 03756 USA
[3] Bates Coll, Boston, MA USA
[4] Dartmouth Coll, 1 Med Ctr Dr, Lebanon, NH 03756 USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DDDR-12
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Monensin and its analogues show anti-glioblastoma activity in an organoid model of cancer
    Urbaniak, Alicja
    Reed, Megan R.
    Heflin, Billie
    Gaydos, John
    Pina-Oviedo, Sergio
    Jedrzejczyk, Marta
    Klejborowska, Greta
    Stepczynska, Natalia
    FASEB JOURNAL, 2022, 36
  • [32] Triethylammonium salt of a synthesized dicoumarol: Structural insight and human anti-glioblastoma activities
    Khan, Afzal
    Ikram, Muhammad
    Rehman, Sadia
    Khan, Rizwan
    Puduvalli, Vinay K.
    Jadoon, Ayub
    Khan, Momin
    Alasmari, Fawaz
    AlAsmari, Abdullah F.
    HELIYON, 2023, 9 (07)
  • [33] Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents
    Salerno, Silvia
    Barresi, Elisabetta
    Baglini, Emma
    Poggetti, Valeria
    Da Settimo, Federico
    Taliani, Sabrina
    MOLECULES, 2023, 28 (06):
  • [34] PREVENTION AND REGRESSION OF CORONARY ATHEROSCLEROSIS - IS IT SAFE AND EFFICACIOUS THERAPY
    MONTAGUE, T
    TSUYUKI, R
    BURTON, J
    WILLIAMS, R
    DZAVIK, V
    TEO, K
    CHEST, 1994, 105 (03) : 718 - 726
  • [35] Combination Therapy Reduces Existing Anti-AAV Antibody by Logs and Allows for Safe and Efficacious Redosing
    Crudele, Julie M.
    Heffner, Garrett C.
    Klaiman, Jordan M.
    Snyder, Jessica M.
    Lin, David M.
    Linn, Naomi P.
    Lin, I. Winnie
    Bello, Ana Buj
    Childers, Martin K.
    Gray, John T.
    Chamberlain, Jeffrey S.
    Mack, David L.
    MOLECULAR THERAPY, 2019, 27 (04) : 78 - 78
  • [36] miR-370-3p Is a Therapeutic Tool in Anti-glioblastoma Therapy but Is Not an Intratumoral or Cell-free Circulating Biomarker
    Nadaradjane, Arulraj
    Briand, Josephine
    Bougras-Cartron, Gwenola
    Disdero, Valentine
    Vallette, Francois M.
    Frenel, Jean-Sebastien
    Cartron, Pierre-Francois
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 13 : 642 - 650
  • [37] Is rapid withdrawal of anti-epileptic drug therapy during video EEG monitoring safe and efficacious?
    Rizvi, Syed A. A.
    Hernandez-Ronquillo, Lizbeth
    Wu, Adam
    Zenteno, Jose F. Tellez
    EPILEPSY RESEARCH, 2014, 108 (04) : 755 - 764
  • [38] High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity
    Lee, Sohyon
    Weiss, Tobias
    Buehler, Marcel
    Mena, Julien
    Lottenbach, Zuzanna
    Wegmann, Rebekka
    Sun, Miaomiao
    Bihl, Michel
    Augustynek, Bartlomiej
    Baumann, Sven P.
    Goetze, Sandra
    van Drogen, Audrey
    Pedrioli, Patrick G. A.
    Penton, David
    Festl, Yasmin
    Buck, Alicia
    Kirschenbaum, Daniel
    Zeitlberger, Anna M.
    Neidert, Marian C.
    Vasella, Flavio
    Rushing, Elisabeth J.
    Wollscheid, Bernd
    Hediger, Matthias A.
    Weller, Michael
    Snijder, Berend
    NATURE MEDICINE, 2024, 30 (11)
  • [39] Extracellular matrix of normal brain tissue is affected by temozolomide during anti-glioblastoma treatment
    Tsidulko, A.
    Bezier, C.
    de La Bourdonnaye, G.
    Suhovskih, A. V.
    Kazanskaya, G.
    Aidagulova, S.
    Grigorieva, E. V.
    ANNALS OF ONCOLOGY, 2018, 29 : 12 - 12
  • [40] Analysis of Clinical Success and Molecular Mechanisms of Action of Novel Anti-glioblastoma Drugs: A Review
    Abdullaeva, Sabina
    Chubarev, Vladimir
    Valeeva, Anna
    Preferanskaya, Nina
    Neganova, Margarita
    Smolyarchuk, Elena
    Liu, Junqi
    Sukocheva, Olga
    Samsonov, Mikhail
    Alyautdin, Renad
    CURRENT MEDICINAL CHEMISTRY, 2025, 32 (06) : 1082 - 1102
12345